LTB4R2 and cancer: The expression of receptors for 5-LO metabolites, including the LTB4 receptors BLT1 and BLT2, have also been shown to be upregulated in a variety of cancers indicating the relevance of the metabolites and accompanying receptors as molecular therapeutic targets [28,34].